-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
Opinion -
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
-
Greggs’ recipe for success on the high street
Greggs grew from a shop founded in Newcastle after the war into a national treasure. Profits will continue to roll in for patient investors, says Jamie Ward
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
-
Stock market turmoil: ‘Should I move money out of investments and into cash instead?’
As global stock markets go into turmoil over Trump tariffs, you may be wondering if your money is safe or whether you should sell your shares and move to the so-called safety net of cash accounts
-
Cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
Opinion -
PZ Cussons share price down 75% in last decade
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
Opinion -
Cash in on the biotech sector with specialist BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
Opinion
